Sovos Brands, Inc. (SOVO) Announces 8.5M Share Secondary Offering

Sovos Brands, Inc. (“Sovos Brands”) (Nasdaq: SOVO), one of the fastest growing food companies of scale in the United States, today announced that certain stockholders of Sovos Brands (the “Selling Stockholders”) intend to offer 8,500,000 shares of Sovos Brands’ common stock, par value $0.001 per share (the “Common Stock”), in an underwritten secondary public offering. The Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 1,275,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions. The offering consists entirely of secondary shares to be sold by the Selling Stockholders. The Selling Stockholders will receive all of the proceeds from the offering.

J.P. Morgan and Goldman Sachs are acting as joint lead book-running managers for the proposed offering. BofA Securities, Credit Suisse, Barclays, UBS Investment Bank, Cowen, Piper Sandler, Stifel and William Blair will also act as book-running managers and Telsey Advisory Group, Drexel Hamilton and Loop Capital Markets will act as co-managers for the proposed offering.

The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to this offering, when available, may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 866-803-9204 or by email at [email protected]; or Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526 or by email at [email protected].

A registration statement on Form S-1 relating to these securities has been filed with the United States Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy these securities be accepted, prior to the time the registration statement becomes effective.

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• ADARx Pharmaceuticals prices $446.3M IPO at $17 per share
• Select Water Solutions to acquire Pilot Water Solutions for $715M
• Live Oak Acquisition Corp. VI raises $230M in Nasdaq IPO